MicroRNAs Influence the Migratory Ability of Human Umbilical Vein Endothelial Cells.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
02 04 2022
Historique:
received: 18 02 2022
revised: 30 03 2022
accepted: 31 03 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

To identify miRNAs that are involved in cell migration in human umbilical vein endothelial cells (HUVECs), we employed RNA sequencing under high glucose incubation and text mining within the databases miRWalk and TargetScanHuman using 83 genes that regulate HUVECs migration. From both databases, 307 predicted miRNAs were retrieved. Differentially expressed miRNAs were determined by exposing HUVECs to high glucose stimulation, which significantly inhibited the migratory ability of HUVECs as compared to cells cultured in normal glucose. A total of 35 miRNAs were found as differently expressed miRNAs in miRNA sequencing, and 4 miRNAs, namely miR-21-3p, miR-107, miR-143-3p, and miR-106b-5p, were identified as overlapping hits. These were subjected to hub gene analysis and pathway analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG), identifing 71 pathways which were influenced by all four miRNAs. The influence of all four miRNAs on HUVEC migration was phenomorphologically confirmed. miR21 and miR107 promoted migration in HUVECs while miR106b and miR143 inhibited migration. Pathway analysis also revealed eight shared pathways between the four miRNAs. Protein-protein interaction (PPI) network analysis was then performed to predict the functionality of interacting genes or proteins. This revealed six hub genes which could firstly be predicted to be related to HUVEC migration.

Identifiants

pubmed: 35456446
pii: genes13040640
doi: 10.3390/genes13040640
pmc: PMC9029696
pii:
doi:

Substances chimiques

MIRN143 microRNA, human 0
MIRN21 microRNA, human 0
MicroRNAs 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Cell Mol Med. 2013 Aug;17(8):1006-15
pubmed: 23802567
Sci Rep. 2015 Aug 21;5:13316
pubmed: 26294080
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Biomol Screen. 2008 Aug;13(7):575-80
pubmed: 18599879
Circ Res. 2007 Mar 30;100(6):782-94
pubmed: 17395884
Exp Mol Med. 2011 Apr 30;43(4):179-88
pubmed: 21350328
FEBS Lett. 2005 Dec 19;579(30):6796-802
pubmed: 16325183
BMC Syst Biol. 2014;8 Suppl 4:S11
pubmed: 25521941
Lipids Health Dis. 2016 Mar 09;15:51
pubmed: 26956882
Cells. 2020 Jul 02;9(7):
pubmed: 32630670
EMBO J. 2012 Apr 4;31(7):1752-63
pubmed: 22373578
Cancer Lett. 2015 Jun 28;362(1):70-82
pubmed: 25827072
Nat Commun. 2017 Sep 28;8(1):726
pubmed: 28959057
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W316-22
pubmed: 21715386
Ann Transl Med. 2019 May;7(9):199
pubmed: 31205917
BMC Bioinformatics. 2017 Mar 20;18(1):180
pubmed: 28320324
Nature. 2011 May 19;473(7347):298-307
pubmed: 21593862
J Nanobiotechnology. 2020 May 6;18(1):68
pubmed: 32375794
Elife. 2015 Mar 30;4:e06734
pubmed: 25821988
Microvasc Res. 2010 Dec;80(3):332-8
pubmed: 20471990
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361
pubmed: 27899662
Sci Rep. 2019 Sep 6;9(1):12861
pubmed: 31492946
J Ginseng Res. 2016 Oct;40(4):325-333
pubmed: 27746684
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Pharmacol Res Perspect. 2016 Jul 12;4(4):e00243
pubmed: 28116096
Cancer Manag Res. 2020 Aug 21;12:7561-7568
pubmed: 32922071
Clin Epigenetics. 2020 Jun 9;12(1):82
pubmed: 32517789
Nature. 2004 Sep 16;431(7006):350-5
pubmed: 15372042
BMC Bioinformatics. 2018 Dec 19;19(1):534
pubmed: 30567491
FEBS Lett. 2017 Jan;591(1):145-154
pubmed: 27926990
Front Oncol. 2020 Mar 13;10:292
pubmed: 32231998
Eur J Cell Biol. 2017 Dec;96(8):758-766
pubmed: 29042072
Toxicol Sci. 2014 Aug 1;140(2):315-26
pubmed: 24863965
Zhonghua Yi Xue Za Zhi. 2006 Dec 26;86(48):3425-30
pubmed: 17313857
Eur J Pharm Sci. 2009 Nov 5;38(4):370-7
pubmed: 19733659
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Circ Res. 2013 Apr 26;112(9):1288-302
pubmed: 23620237
Mediators Inflamm. 2019 Oct 7;2019:6168340
pubmed: 31686985
Biochem Biophys Res Commun. 2017 Jun 17;488(1):159-164
pubmed: 28483528
Mod Pathol. 2015 Jun;28(6):845-853
pubmed: 25676555
Circ Res. 2015 May 22;116(11):1753-64
pubmed: 25801897
Int J Stem Cells. 2011 Jun;4(1):24-34
pubmed: 24298331

Auteurs

Zhaohui Wang (Z)

Vascular Surgery, University Clinic Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
BioQuant, Heidelberg University, 69120 Heidelberg, Germany.

Ziwei Zeng (Z)

Vascular Surgery, University Clinic Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
BioQuant, Heidelberg University, 69120 Heidelberg, Germany.

Vytaute Starkuviene (V)

BioQuant, Heidelberg University, 69120 Heidelberg, Germany.
Institute of Biosciences, Vilnius University Life Sciences Center, 10257 Vilnius, Lithuania.

Holger Erfle (H)

BioQuant, Heidelberg University, 69120 Heidelberg, Germany.

Kejia Kan (K)

Vascular Surgery, University Clinic Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
BioQuant, Heidelberg University, 69120 Heidelberg, Germany.

Jian Zhang (J)

Vascular Surgery, University Clinic Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
BioQuant, Heidelberg University, 69120 Heidelberg, Germany.

Manuel Gunkel (M)

BioQuant, Heidelberg University, 69120 Heidelberg, Germany.

Carsten Sticht (C)

NGS Core Facility, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.

Nuh Rahbari (N)

Vascular Surgery, University Clinic Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.

Michael Keese (M)

Vascular Surgery, University Clinic Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.
European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH